Cat Vaccines

Global Cat Vaccines Market to Reach US$1.7 Billion by 2030

The global market for Cat Vaccines estimated at US$1.1 Billion in the year 2024, is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 8.1% over the analysis period 2024-2030. Modified / Attenuated Live Vaccines, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$965.1 Million by the end of the analysis period. Growth in the Inactivated Vaccines segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$290.8 Million While China is Forecast to Grow at 12.8% CAGR

The Cat Vaccines market in the U.S. is estimated at US$290.8 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$369.7 Million by the year 2030 trailing a CAGR of 12.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.0% and 7.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.

Global Cat Vaccines Market – Key Trends & Drivers Summarized

Why Is the Demand for Cat Vaccines Increasing?

The growing awareness of feline health and the increasing adoption of preventive veterinary care have significantly boosted the demand for cat vaccines worldwide. As pet ownership continues to rise, more cat owners are prioritizing regular vaccinations to protect their pets from life-threatening diseases such as feline leukemia virus (FeLV), rabies, and feline calicivirus (FCV). The shift toward preventative healthcare in the pet industry has made vaccines an essential component of feline wellness plans. Additionally, governmental and non-governmental organizations are actively promoting vaccination programs, particularly in regions with high stray cat populations. With an increased focus on zoonotic disease prevention, regulatory authorities are strengthening guidelines to ensure widespread vaccine accessibility and compliance. These efforts are further supported by veterinary associations emphasizing the importance of core and non-core vaccinations to prevent outbreaks of contagious feline diseases.

How Are Advancements in Veterinary Medicine Impacting Cat Vaccines?

The field of veterinary medicine is witnessing significant advancements in vaccine development, leading to more effective and long-lasting immunization options for cats. Recombinant DNA technology and vector-based vaccines are enhancing the efficacy and safety of feline vaccines, reducing the risk of adverse reactions while providing longer immunity. These innovations have led to the development of novel vaccines that offer improved protection against multiple strains of viruses and bacteria. Moreover, the introduction of intranasal and non-adjuvanted vaccines is addressing concerns over injection-site reactions, making vaccinations more comfortable for cats. Advances in immunology have also paved the way for personalized vaccination schedules, ensuring that feline vaccinations are tailored based on age, health status, and lifestyle factors. With ongoing research in veterinary biotechnology, the market is expected to benefit from continuous improvements in vaccine formulations and delivery methods.

What Market Trends Are Driving the Adoption of Cat Vaccines?

One of the major trends shaping the cat vaccine market is the increasing preference for combination vaccines. These formulations provide immunity against multiple diseases in a single dose, reducing the need for multiple veterinary visits while ensuring comprehensive protection. The demand for these vaccines is particularly high among pet owners who seek convenient and cost-effective immunization options for their cats. Another emerging trend is the rising adoption of preventive veterinary care packages offered by pet insurance providers and veterinary clinics. These packages often include routine vaccinations, diagnostic screenings, and parasite control measures, encouraging higher vaccine uptake. Additionally, the growing penetration of e-commerce in the pet healthcare sector is making veterinary vaccines more accessible, with online platforms facilitating home delivery and subscription-based vaccine services.

What Are the Key Growth Drivers in the Cat Vaccines Market?

The growth in the Cat Vaccines market is driven by several factors, including increasing pet ownership, advancements in vaccine technology, and the rising prevalence of feline infectious diseases. The expansion of veterinary healthcare infrastructure, particularly in emerging markets, is also contributing to market growth by improving access to high-quality vaccination services. Additionally, regulatory mandates for rabies vaccination and other feline disease prevention programs are fueling vaccine adoption. The growing focus on pet welfare and responsible pet ownership is leading to higher compliance rates for routine vaccinations. Furthermore, the expansion of research initiatives targeting feline-specific diseases is expected to introduce new and more effective vaccines in the coming years. As veterinary medicine continues to evolve, cat vaccines will remain a crucial component of feline healthcare, ensuring the well-being of domestic and stray cat populations globally.

SCOPE OF STUDY:

The report analyzes the Cat Vaccines market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Vaccine Type (Modified/Attenuated Live Vaccines, Inactivated Vaccines, Other Vaccine Types); Disease (Feline Respiratory Diseases, Feline Leukemia Diseases, Feline Panleukopenia Diseases, Feline Rabies Diseases, Other Diseases); Route of Administration (Injectables Route of Administration, Intranasal Route of Administration); Duration of Immunity (1 Year Duration of Immunity, 3 Years Duration of Immunity, Other Durations of Immunities)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• Bioveta, a. s.
• Boehringer Ingelheim International GmbH
• Durvet Inc.
• Elanco Animal Health Incorporated
• Greencross Vets
• Indian Immunologicals Ltd.
• Mars, Inc.
• Medivet
• Merck Animal Health
• Petco Animal Supplies, Inc.
• The Vets Holding Inc.
• VIRBAC Animal Health India Private Ltd.
• Virbac SA
• Zoetis, Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.